News Alert

Providers Generally Supportive, PhRMA Pans Final 340B Dispute Resolution Rule

After HHS released the long-awaited final rule for resolving 340B administrative disputes, provider groups generally supported and PhRMA denounced the updated process.
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie, BI Agree to Lift 340B Contract Pharmacy Restrictions in Arkansas, Making It 21 Manufacturers to End or Loosen Restrictions

Boehringer Ingelheim became one of the latest major drugmakers to exempt Arkansas covered entities from its 340B contract pharmacy restrictions.
Drugmakers AbbVie and Boehringer Ingelheim (BI) have agreed in principle to exempt Arkansas providers from their 340B contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck Adds Biologic to Contract Pharmacy Restrictions

Pharmaceutical giant Merck has added a new medication for pulmonary arterial hypertension to its 340B contract pharmacy restrictions.
Merck has added an injectable medication used to treat pulmonary arterial hypertension—a type of high blood pressure which affects the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

HRSA Issues Final Regulations Revamping Process to Resolve Disputes Between 340B Providers and Manufacturers

Federal officials have released the long-awaited final rule for the 340B Administrative Dispute Resolution process.
The federal government issued the final rule early Thursday to implement a long-anticipated revision to the 340B Administrative Dispute Resolution [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

White House Completes Review of Final Rule for 340B Dispute Process, Release Expected Soon

The Department of Health and Human Services is expected to soon release its final 340B administrative dispute resolution rule after the White House completed its final review this week.
After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Asks Full Appeals Court to Rehear Arkansas 340B Contract Pharmacy Case

PhRMA has asked the full panel of judges on the U.S. 8th Circuit Court of Appeals to rehear a case on Arkansas' 340B contract pharmacy access law.
An influential drug industry trade group has asked a full federal appeals court to rehear a case on the constitutionality [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie Replies to Louisiana’s Request for Court to Expedite Decision on Contract Pharmacy Law

Drug manufacturer AbbVie is challenging Louisiana's state 340B contract pharmacy access law in a federal district court.
Drug manufacturer AbbVie recently replied to Louisiana’s request for summary judgement and defended its own such request in its ongoing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AstraZeneca’s Lawsuit Against Arkansas’ 340B Contract Pharmacy Law Reassigned to Judge Who Previously Upheld It

AstraZeneca's lawsuit challenging Arkansas' 340B contract pharmacy access law has been transferred to a federal judge who previously upheld it.
A federal district court has transferred drugmaker AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law to a judge who [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Manufacturer Refunds to 340B Providers Have Steadily Increased Since 2019, Says Analysis

An analysis from the law firm Spencer Fane found that 340B refunds have been concentrated among certain manufacturers and drugs.
A recent analysis of the increasing annual total number of drug manufacturer refunds to 340B covered entities notes they are [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Teva Adds Blood Therapy Drug to Hospital Contract Pharmacy Restrictions

Drugmaker Teva has added a blood therapy medication to its existing contract pharmacy restrictions for 340B hospitals.
Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live